This present study was consistent with reports from earlier studies that treatment with Polygonum cuspidatum, curcumin, and butein inhibited the EGFR-Erk1/2 cascade signaling pathway, resulting in the inhibition of osteosarcoma [39,40,41]. The gene discussed is MAPK3; the disease is osteosarcoma.